Pelthos Therapeutics cut to neutral from buy by Alliance Global Partners
PTHS•Alliance Global Partners cut its rating on Pelthos Therapeutics to neutral from buy.
Related News
European stocks set for weekly gain, dollar near 19-month high on rate hike bets
SPY•
Collective Mining management attributes wider Q3 2026 net loss to expanded exploration
CNL•
Centuri Holdings director Anne L. Mariucci reports acquisition of $99,990 in common shares
CTRI•
Biglari Holdings Chairman and CEO Sardar Biglari reports $5.54 million common share acquisition
BH•
CVS Health Corporation: Bernstein cuts target price to $106 from $112
CVS•